Corporate overview

View all
Carmell Announces Successful Closing of $3.0 Million Private Placement
Carmell Announces $3.0 Million Private Placement
Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction
Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary
Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics Field
Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024

SEC Filings

Please click the link below to access our SEC filings.

SEC Website

Governance Documents